About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Management of Hyperglycemia: Impact on Complications in the CVOT Era
By
Scripps Health: 2019 Updates in Diabetes Management
FEATURING
Daniel Einhorn
June 26, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
01:13
Novo Nordisk – GLP-1 RA Therapy
ADA Guidelines for T2D: What Is the Preferred Next Step After Oral Agents?
Feat.
C. Wierum,
L. Coco
Featured Video
11:40
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal Insulin
Feat.
C. Wierum,
L. Coco
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
12:04
Stephen Kopecky
Role of PCSK9 Inhibitors in Diabetes
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century - Almo…
Feat.
R. DeFronzo
28:13
National Lipid Association
New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty Acids…
Feat.
R. Mason
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibition
Feat.
R. DeFronzo
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a…
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
11:50
American Heart & Vascular Institute
New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. Where …
Feat.
M. Kittleson
67:29
Philips
Step Ahead - PAD & CLI State of the Art and the COVID 19 Era Impacts o…
Feat.
C. Walker,
C. Lesar,
S. Madassery,
T. Yates
83:52
Philips
Step Ahead - Beyond the Intervention leading limb salvage outcomes
Feat.
F. Saab,
J. Griffin,
J. Mendivil
17:35
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhib…
Feat.
B. Greenberg
12:23
American Heart & Vascular Institute
SGLT2 Inhibitors for HF: Is this Therapy Helpful for Reducing the Hospital…
Feat.
M. Tipton
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…
Feat.
G. Umpierrez
21:10
National Lipid Association
Plant-based Diets for Improving Lipids
Feat.
K. Williams
27:02
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
Feat.
A. Lala-Trindade
15:25
Javed Butler
SGLT2 Inhibitors and Heart Failure in Type-2 Diabetes Mellitus
57:22
3M+KCI
Surgical Site Infections Reduction Strategies in Vascular Surgery from Sta…
Feat.
R. C. Prielipp,
E. Dillavou
83:52
Philips
Diagnosis and Management of CLI: How to Build Multidisciplinary Care Teams…
Feat.
J. Griffin,
J. Mendivil,
l. henderson,
F. Saab
17:16
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Approaches to Treating Diabetes that Reduce CV Events: How Effective Are D…
Feat.
J. Shen
